Drug Maker Shares Soar as Clinical Trial Shows Remdesivir Helping Coronavirus Patients

From the story: The trial, conducted by the University of Chicago Medicine, found nearly all patients who were given daily infusions of Remdesivir were discharged from the hospital in less than a week. The university recruited 125 coronavirus patients, 113 of which had “severe disease” into two clinical trials to assess five and 10-day treatment courses of the drug (Fox Business).  

And a group is studying dogs to see if they can sniff out the coronavirus (NY Post).